The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus
Sponsor
Haydarpasa Numune State Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00463502
Collaborator
(none)
Study Details
Study Description
Brief Summary
Aim: To investigate the effects of metformin treatment on thyroid hormone metabolism in euthyroid patients with type 2 diabetes mellitus.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 4 |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
35 Years
to 78 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- The patients included in this study were the ones who were newly diagnosed with type 2 diabetes mellitus
Exclusion Criteria:
- Presence of thyroid disorders, positive thyroid autoantibodies and usage of medications affecting thyroid hormones such as amiodarone, lithium were accepted as exclusion criterions
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Haydarpasa Numune State Hospital
Investigators
- Principal Investigator: Ali Ozdemir, Unaffiliation
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00463502
Other Study ID Numbers:
- 07-013
First Posted:
Apr 20, 2007
Last Update Posted:
Apr 20, 2007
Last Verified:
Mar 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: